Fundraising Fox
Shire
Techstars '23Middletown, US · 2 employees on LinkedIn · 2 known investors
Find your way into Shire
Sign up to see every warm intro you have to Shire
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Shire team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Shire builds a digital office platform for volunteer-heavy organizations like political campaigns and nonprofits, enabling remote volunteer onboarding, engagement, and training at scale.
Founders & leadership
Investors · 2
How we know: Creative HQ — The Incubator's portfolio page · Not right? Tell us
How we know: the Techstars portfolio · Not right? Tell us
Acquisitions · 8
Early investors' stakes continue via these dealsAdvanced BioHealing was a regenerative medicine company that commercialized cell-based and tissue-engineered products, notably Dermagraft, a dermal substitute for diabetic foot ulcers.
Bikam Pharmaceuticals developed small molecule therapeutics for degenerative eye diseases, including a pharmacological chaperone compound for autosomal dominant retinitis pigmentosa.
Dyax Corp was a Burlington, Massachusetts biopharmaceutical company developing plasma kallikrein inhibitors for hereditary angioedema, marketing Kalbitor and advancing DX-2930, plus running a phage-display licensing business.
Developed a next-generation iron chelator for iron overload in transfusion-dependent anemia; acquired by Shire in 2012.
Lumena Pharmaceuticals was a San Diego-based biopharmaceutical company founded in 2011 that developed oral bile-acid transporter inhibitor drugs for rare pediatric and adult cholestatic liver diseases such as Alagille syndrome and PFIC.
Acquired by Shire in 2014 (now part of Takeda).
Specialty pharma treating Eosinophilic Esophagitis; acquired by Shire for up to $245M in 2015.
Movetis was a Belgian pharmaceutical company spun off from Johnson & Johnson in 2006, focused on gastrointestinal drugs including prucalopride (Resolor) for chronic constipation.
Frequently asked questions
- What does Shire do?
- Shire builds a digital office platform for volunteer-heavy organizations like political campaigns and nonprofits, enabling remote volunteer onboarding, engagement, and training at scale.
- Who founded Shire?
- Shire was founded by Samantha Boucher, Edward Monical-Vuylsteke.
- Who are Shire's investors?
- Shire's investors include Creative HQ — The Incubator, Techstars.
- Where is Shire headquartered?
- Shire is headquartered in Middletown, US.